Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Michalowski

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Cell Systems|June 22, 2023
Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomicsDavid B Morse, Aleksandra M Michalowski, Michele Ceribelli, et al.
Nature Communications|October 14, 2018
Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplexDavid R Calabrese, Xiang Chen, Elena C Leon, et al.
Molecular Cancer Therapeutics|May 20, 2017
Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC DegradationJohn K Simmons, Aleksandra M Michalowski, Benjamin J Gamache, et al.
Molecular Cancer Therapeutics|August 5, 2020
Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL TumorigenesisJoy M Gary, John K Simmons, Jinfei Xu, et al.
Molecular Cancer Research : MCR|June 6, 2019
T-Cell Deletion of MyD88 Connects IL17 and IκBζ to RAS OncogenesisChristophe Cataisson, Rosalba Salcedo, Aleksandra M Michalowski, et al.
Nature Communications|January 18, 2020
Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasisKerrie L Marie, Antonella Sassano, Howard H Yang, et al.
Nature Medicine|April 15, 2020
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapyEva Pérez-Guijarro, Howard H Yang, Romina E Araya, et al.
Nature Medicine|January 30, 2021
Author Correction: Multimodel preclinical platform predicts clinical response of melanoma to immunotherapyEva Pérez-Guijarro, Howard H Yang, Romina E Araya, et al.
Cancer Letters|June 25, 2023
Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myelomaTyler J Peat, Snehal M Gaikwad, Wendy Dubois, et al.
Science Translational Medicine|November 22, 2019
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screeningGrant L Lin, Kelli M Wilson, Michele Ceribelli, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Cell Systems|June 22, 2023
Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomicsDavid B Morse, Aleksandra M Michalowski, Michele Ceribelli, et al.
Nature Communications|October 14, 2018
Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplexDavid R Calabrese, Xiang Chen, Elena C Leon, et al.
Molecular Cancer Therapeutics|May 20, 2017
Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC DegradationJohn K Simmons, Aleksandra M Michalowski, Benjamin J Gamache, et al.
Molecular Cancer Therapeutics|August 5, 2020
Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL TumorigenesisJoy M Gary, John K Simmons, Jinfei Xu, et al.
Molecular Cancer Research : MCR|June 6, 2019
T-Cell Deletion of MyD88 Connects IL17 and IκBζ to RAS OncogenesisChristophe Cataisson, Rosalba Salcedo, Aleksandra M Michalowski, et al.
Nature Communications|January 18, 2020
Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasisKerrie L Marie, Antonella Sassano, Howard H Yang, et al.
Nature Medicine|April 15, 2020
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapyEva Pérez-Guijarro, Howard H Yang, Romina E Araya, et al.
Nature Medicine|January 30, 2021
Author Correction: Multimodel preclinical platform predicts clinical response of melanoma to immunotherapyEva Pérez-Guijarro, Howard H Yang, Romina E Araya, et al.
Cancer Letters|June 25, 2023
Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myelomaTyler J Peat, Snehal M Gaikwad, Wendy Dubois, et al.
Science Translational Medicine|November 22, 2019
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screeningGrant L Lin, Kelli M Wilson, Michele Ceribelli, et al.
Pageof 5